Baffour Awuah
Kumasi, AH, Ghana
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Breast Cancer Incidence Rates in Ghanaian and US Black Women From 2013 Through 2015.
Journal: JAMA network open
Published: October 13, 2025
Etiology of gene expression-based subtypes of breast cancer in the Ghana Breast Health Study.
Journal: International journal of cancer
Published: July 18, 2025
Oncologic Anthropology and the African Diaspora: Twenty-Year Anniversary Report, International Center for the Study of Breast Cancer Subtypes (ICSBCS).
Journal: Annals of surgical oncology
Published: March 26, 2025
Contribution of Prediagnostic Host Factors to Shaping the Stromal Microenvironment of Breast Cancer among Sub-Saharan African Women.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: March 11, 2024
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition.
Journal: Cancer research
Published: March 08, 2024
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Journal: bioRxiv : the preprint server for biology
Published: December 11, 2023
ACHIEVE conference proceedings: implementing action plans to reduce and control hypertension burden in Africa.
Journal: Journal of human hypertension
Published: November 25, 2023
Associations of Circulating Estrogens and Estrogen Metabolites with Fecal and Oral Microbiome in Postmenopausal Women in the Ghana Breast Health Study.
Journal: Microbiology spectrum
Published: June 21, 2023
Mosquito control exposures and breast cancer risk: analysis of 1071 cases and 2096 controls from the Ghana Breast Health Study.
Journal: Breast cancer research : BCR
Published: June 19, 2023
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Journal: Cancer letters
Published: June 12, 2023
Last Updated: 09/26/2026